Amplitude Surgical: Acquisition of a 50% Stake in SOFAB Orthopédie, a Strategic Industrial Subcontractor

VALENCE, France–(BUSINESS WIRE)–Regulatory News:

Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading player on the global surgical technology market for lower-limb orthopedics, announces having acquired a 50% stake in SOFAB Orthopédie, a longstanding strategic industrial subcontractor.

Commenting on this newly-acquired stake, Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: “Following the construction of a logistics site and the launch of work to create our own ‘clean room’, the acquisition of a stake in SOFAB Orthopédie – an industrial subcontractor – is another strategic investment aimed at consolidating our industrial base and our supply chain within a context of the pursuance of our buoyant business growth.”

Yann Quinkal, CEO of the SOFAB Orthopédie group, adds: “This deal with Amplitude Surgical will enable us to continue our development alongside a longstanding partner that shares our vision of total quality.”

Founded in July 2007 and based near Valence in the Rhone valley, the SOFAB Orthopédie group incorporates FIRM Industrie, POLI ALPES and POLI-TECH’, three ISO 9001 and ISO 13485 certified companies specializing in the end-to-end manufacturing of implants and ancillaries, from machining to polishing and engraving. The Group employs close to 80 staff and generates annual revenue of almost €5 million, 80% of which comes from Amplitude Surgical. Yann Quinkal will continue to head this activity in close collaboration with the Amplitude Surgical teams.

Amplitude Surgical will consolidate in full SOFAB Orthopédie from the second half of 2016-17 and expects this transaction to provide a net positive contribution from 2017-18.

Next financial press release: H1 2016-17 sales, Wednesday February 15, 2017, after market.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. Amplitude Surgical distributes its products in more than 30 countries. At June 30, 2016, Amplitude Surgical had a workforce of almost 300 employees and recorded sales of over 80 million euros.